Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
Clinical trial NCT06830759 · RECRUITING
Trial details
- NCT number
- NCT06830759
- Sponsor
- AbbVie
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-03-28
- Primary completion
- 2031-09-01
- Enrollment
- 700
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.